CHRISTOPHER J. NEUGENT - 01 Mar 2023 Form 4 Insider Report for Cibus, Inc. (CBUS)

Role: Director
Signature: Suzette McNally, Attorney-in-Fact for Christopher J. Neugent
Issuer symbol: CBUS
Transactions as of: 01 Mar 2023
Net transactions value: $0
Form type: 4
Filing time: 01 Jun 2023, 19:11:49 UTC
Previous filing: 15 Jun 2022
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Shares	Change %	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CBUS	Stock Option (Right-to-Buy)	Disposed to Issuer	-7,500	-100%	0	01 Mar 2023	Common Stock	7,500	$4.55	Direct	F1
transaction	CBUS	Stock Option (Right-to-Buy)	Award	+7,500		7,500	01 Mar 2023	Common Stock	7,500	$4.55	Direct	F1
transaction	CBUS	Stock Option (Right-to-Buy)	Disposed to Issuer	-14,408	-100%	0	01 Mar 2023	Common Stock	14,408	$4.22	Direct	F1
transaction	CBUS	Stock Option (Right-to-Buy)	Award	+14,408		14,408	01 Mar 2023	Common Stock	14,408	$4.22	Direct	F1
transaction	CBUS	Stock Option (Right-to-Buy)	Disposed to Issuer	-36,400	-100%	0	01 Mar 2023	Common Stock	36,400	$0.3032	Direct	F1
transaction	CBUS	Stock Option (Right-to-Buy)	Award	+36,400		36,400	01 Mar 2023	Common Stock	36,400	$0.3032	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

CHRISTOPHER J. NEUGENT is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id	Content
F1	The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split.

Content

The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split.